393 материалов по теме, собраны автоматически из проверенных источников
Radiation Oncology’s Biggest Meeting Returns to Boston With Landmark Trials in Breast, Liver and Lung Cancer Bioengineer.org
Ifinatamab Deruxtecan Biologics License Application for Certain Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer Voluntarily Withdrawn Business Wire
A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that a dietary form of a naturally occurring molecule called calcium alpha-ketoglutarate, or Ca-αKG, reduced lung tumor growth in female mice and activated genes associated with better outcomes in women with lung cancer. The…
Optimizing Perioperative Treatment in Resectable Non-Small Cell Lung Cancer Oncology News Central
Researchers at The University of Texas MD Anderson Cancer Center have developed an artificial intelligence (AI) model that can identify lung cancer patients at increased risk of developing a serious immunotherapy-related side effect before treatment begins, offering a possible path toward more personalized monitoring…
Astellas moves KRAS G12D degrader setidegrasib into Phase III lung cancer trial AllSci
Human breath could help identify cancerous lung nodules and reduce the need for invasive testing. New Griffith University research analyzed exhaled breath to help doctors distinguish between cancerous and noncancerous lung nodules, supporting earlier lung cancer diagnosis. Approximately 2.5 million new cases of lung…
UK Approves Lurbinectedin Plus Atezolizumab as First-Line Maintenance Therapy for Small Cell Lung Cancer Oncodaily
Precision Radiation Therapy Alone Doubles Historical Survival Rates for Inoperable Lung Cancer, Landmark Lancet Trial Finds PR Newswire
Astellas Starts Phase 3 Trial of Setidegrasib vs Docetaxel in KRAS G12D Lung Cancer The Clinical Trial Vanguard
Osimertinib Maintains 8-Year Overall Survival in EGFR+ Lung Cancer Oncology News Central
SystImmune hits USD 250m milestone from BMS as iza-bren Phase III lung cancer trial advances AllSci
About 30,000 new lung cancer cases occur yearly in Spain and Portugal; a trial has approval to screen patients there. Stock Titan
A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment. It strengthened existing therapies, restored drug sensitivity in resistant lung cancer cells, and slowed tumor growth in animal models.
Which Is the Bigger Story for BioNTech -- Its Colorectal Cancer Vaccine Setback or the Lung Cancer Clinical Success? The Motley Fool